Gossens et al. [41] identified that a novel BCL11B-ZEB2 fusion with its fusion partner 5′ BCL11B enhanced the ZEB2 expression in ETP-ALL. This evidence concerns the gene ZEB2 and acute lymphoblastic leukemia.